This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
H.B. Fuller has launched Swift®melt 1515-I adhesive, its first bio-compatible product compliant in India, Middle East, and Africa (IMEA). The product is intended for medical tape applications used in stick-to-skin under unique climatic conditions, such as the high temperatures and humidity in the Indian sub-continent.
Swift®melt 1515-I delivers effective high-tack, secure, quick bonding under high temperatures and with shear resistance. The product, which balances adhesion and ease of removal, was thoroughly tested and certified by ISO 10993-5 for cytotoxicity. Since it is not toxic to human cells, the adhesive can effectively be used in medical applications in hospitals and home care in stick-to-skin situations.
“This is a breakthrough from our H.B. Fuller’s R&D team in India, which has developed this new technology in our lab in Pune, in response to the IMEA market specifics to support advanced stick-to-skin product compliant for medical use, such as medical plasters or bandages,” says Manish Dwivedi, flexible materials, business manager for India. “Globally, our products have been used around the world in medical applications for more than two decades, enabling diverse new ideas and accelerating innovation for this important industry.”
The population pressure, the growing prevalence of diseases, and the increasing number of surgeries and chronic and traumatic wounds make the global medical tapes and bandages market one that is significantly rising. The segment is expected to reach $8.59 billion by 2026 globally, $850.1 million of which in India, as reported on the “Medical Tapes and Bandages Market – Global Forecast 2026” by MarketsandMarkets™.
